AUD 0.0
(-20.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 7.31 Million AUD | 118.78% |
2022 | 3.34 Million AUD | -36.23% |
2021 | 5.24 Million AUD | 56.38% |
2020 | 3.35 Million AUD | -36.89% |
2019 | 5.31 Million AUD | 10.69% |
2018 | 4.8 Million AUD | -41.72% |
2017 | 8.23 Million AUD | -38.3% |
2016 | 13.35 Million AUD | -56.56% |
2015 | 30.74 Million AUD | -39.6% |
2014 | 50.9 Million AUD | 18.49% |
2013 | 42.95 Million AUD | -33.0% |
2012 | 64.12 Million AUD | -16.27% |
2011 | 76.57 Million AUD | 42.42% |
2010 | 53.76 Million AUD | -20.18% |
2009 | 67.36 Million AUD | -2.64% |
2008 | 69.18 Million AUD | -59.66% |
2007 | 171.52 Million AUD | -1.14% |
2006 | 173.49 Million AUD | 1.42% |
2005 | 171.07 Million AUD | 50.02% |
2004 | 114.03 Million AUD | 287.76% |
2003 | 29.4 Million AUD | 98.19% |
2002 | 14.83 Million AUD | -19.34% |
2001 | 18.39 Million AUD | -11.81% |
2000 | 20.85 Million AUD | 309.32% |
1999 | 5.09 Million AUD | 214.49% |
1998 | 1.62 Million AUD | -70.66% |
1997 | 5.52 Million AUD | -83.27% |
1996 | 33.01 Million AUD | -4.27% |
1995 | 34.48 Million AUD | 208.07% |
1994 | 11.19 Million AUD | -5.74% |
1993 | 11.87 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 5.86 Million AUD | 0.0% |
2023 FY | 7.31 Million AUD | 118.78% |
2023 Q2 | 3.92 Million AUD | 0.0% |
2023 Q4 | 7.31 Million AUD | 0.0% |
2022 Q2 | 4.47 Million AUD | 0.0% |
2022 FY | 3.34 Million AUD | -36.23% |
2022 Q4 | 3.34 Million AUD | 0.0% |
2021 Q4 | 5.24 Million AUD | 0.0% |
2021 FY | 5.24 Million AUD | 56.38% |
2021 Q2 | 6.6 Million AUD | 0.0% |
2020 Q2 | 4.5 Million AUD | 0.0% |
2020 FY | 3.35 Million AUD | -36.89% |
2020 Q4 | 3.35 Million AUD | 0.0% |
2019 Q4 | 5.31 Million AUD | 0.0% |
2019 FY | 5.31 Million AUD | 10.69% |
2019 Q2 | 6.89 Million AUD | 0.0% |
2018 Q2 | 6.81 Million AUD | 0.0% |
2018 FY | 4.8 Million AUD | -41.72% |
2018 Q4 | 4.8 Million AUD | 0.0% |
2017 Q4 | 8.23 Million AUD | 0.0% |
2017 FY | 8.23 Million AUD | -38.3% |
2017 Q2 | 9.04 Million AUD | 0.0% |
2016 Q2 | 25.22 Million AUD | 0.0% |
2016 Q4 | 13.35 Million AUD | 0.0% |
2016 FY | 13.35 Million AUD | -56.56% |
2015 FY | 30.74 Million AUD | -39.6% |
2015 Q2 | 36.78 Million AUD | 0.0% |
2015 Q4 | 30.74 Million AUD | 0.0% |
2014 FY | 50.9 Million AUD | 18.49% |
2014 Q2 | 39.51 Million AUD | 0.0% |
2014 Q4 | 50.9 Million AUD | 0.0% |
2013 Q2 | 49.3 Million AUD | 0.0% |
2013 FY | 42.95 Million AUD | -33.0% |
2013 Q4 | 42.95 Million AUD | 0.0% |
2012 Q4 | 64.12 Million AUD | 0.0% |
2012 FY | 64.12 Million AUD | -16.27% |
2011 FY | 76.57 Million AUD | 42.42% |
2011 Q4 | 76.57 Million AUD | 0.0% |
2010 Q4 | 53.76 Million AUD | 0.0% |
2010 FY | 53.76 Million AUD | -20.18% |
2009 Q4 | 67.36 Million AUD | 0.0% |
2009 FY | 67.36 Million AUD | -2.64% |
2008 FY | 69.18 Million AUD | -59.66% |
2008 Q4 | 69.18 Million AUD | 0.0% |
2007 Q4 | 171.52 Million AUD | 0.0% |
2007 FY | 171.52 Million AUD | -1.14% |
2006 Q4 | 173.49 Million AUD | 0.0% |
2006 FY | 173.49 Million AUD | 1.42% |
2005 FY | 171.07 Million AUD | 50.02% |
2005 Q4 | 171.07 Million AUD | 0.0% |
2004 Q4 | 114.03 Million AUD | 0.0% |
2004 FY | 114.03 Million AUD | 287.76% |
2003 FY | 29.4 Million AUD | 98.19% |
2003 Q4 | 29.4 Million AUD | 0.0% |
2002 FY | 14.83 Million AUD | -19.34% |
2002 Q4 | 14.83 Million AUD | 0.0% |
2001 Q4 | 18.39 Million AUD | 0.0% |
2001 FY | 18.39 Million AUD | -11.81% |
2000 FY | 20.85 Million AUD | 309.32% |
2000 Q4 | 20.85 Million AUD | 0.0% |
1999 Q4 | 5.09 Million AUD | 0.0% |
1999 FY | 5.09 Million AUD | 214.49% |
1998 FY | 1.62 Million AUD | -70.66% |
1998 Q4 | 1.62 Million AUD | 0.0% |
1997 Q4 | 5.52 Million AUD | 0.0% |
1997 FY | 5.52 Million AUD | -83.27% |
1996 FY | 33.01 Million AUD | -4.27% |
1995 FY | 34.48 Million AUD | 208.07% |
1994 FY | 11.19 Million AUD | -5.74% |
1993 FY | 11.87 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AdAlta Limited | 5.57 Million AUD | -31.335% |
Acrux Limited | 8.96 Million AUD | 18.339% |
Amplia Therapeutics Limited | 14.84 Million AUD | 50.695% |
Biome Australia Limited | 8.27 Million AUD | 11.568% |
BTC Health Limited | 5.14 Million AUD | -42.155% |
Chimeric Therapeutics Limited | 15.27 Million AUD | 52.077% |
CSL Limited | 56.93 Billion AUD | 99.987% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 95.267% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 96.833% |
Noxopharm Limited | 6.78 Million AUD | -7.895% |
PharmAust Limited | 11.12 Million AUD | 34.208% |
Proteomics International Laboratories Limited | 10.87 Million AUD | 32.697% |
Prescient Therapeutics Limited | 20.39 Million AUD | 64.108% |
PYC Therapeutics Limited | 91.23 Million AUD | 91.978% |
Race Oncology Limited | 20.22 Million AUD | 63.817% |
Starpharma Holdings Limited | 36.81 Million AUD | 80.118% |
EZZ Life Science Holdings Limited | 25.55 Million AUD | 71.355% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | 93.492% |
Memphasys Limited | 12.43 Million AUD | 41.116% |
Nyrada Inc. | 5.9 Million AUD | -23.904% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -337.909% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 98.162% |
Bio-Gene Technology Limited | 3.15 Million AUD | -131.654% |
Zelira Therapeutics Limited | 5.18 Million AUD | -41.206% |
Patrys Limited | 4.16 Million AUD | -75.878% |
Dimerix Limited | 32.07 Million AUD | 77.183% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 97.048% |
Orthocell Limited | 26.61 Million AUD | 72.5% |
Imugene Limited | 151.39 Million AUD | 95.166% |
Cynata Therapeutics Limited | 8.38 Million AUD | 12.744% |
Immutep Limited | 147.44 Million AUD | 95.036% |
Arovella Therapeutics Limited | 13.28 Million AUD | 44.904% |
Alterity Therapeutics Limited | 19.22 Million AUD | 61.926% |
Nanollose Limited | 241.95 Thousand AUD | -2925.121% |
Invex Therapeutics Ltd | 6.12 Million AUD | -19.596% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -34.648% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -185.412% |
Biotron Limited | 493.47 Thousand AUD | -1383.215% |
Radiopharm Theranostics Limited | 72.03 Million AUD | 89.839% |
Tissue Repair Ltd | 19.38 Million AUD | 62.251% |
AnteoTech Limited | 9.38 Million AUD | 21.979% |
Hexima Limited | 2.26 Million AUD | -222.578% |
Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 73.278% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | -14.91% |
Actinogen Medical Limited | 21.31 Million AUD | 65.656% |
Immuron Limited | 15.54 Million AUD | 52.93% |
Argenica Therapeutics Limited | 16.37 Million AUD | 55.309% |